29 July 2018 - Thousands of Australians will be able to pop a pill once a day for eight weeks to treat Hepatitis C, with a new drug to be listed on the Pharmaceutical Benefits Scheme.
The drug Maviret is due to be put on the PBS from Wednesday and give the estimated 200,000 Aussies living with the condition access to the drug.
It contains two direct-acting anti-viral agents which block the life cycle of the virus in a patient, with doctors saying a patient is "virologically cured" if there are undetectable levels of the virus 12 weeks after completing the treatment.